Li Ping Hong
Director/Board Member bei HONZ PHARMACEUTICAL CO., LTD.
Profil
Li Ping Hong is currently the Vice Chairman & Vice President at Honz Pharmaceutical Co., Ltd., the Director at Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd., the Director at Hainan Honz Pharmaceutical Sales Co. Ltd., the General Manager & Executive Director at Guangdong Kangzhi Hospital Management Co., Ltd., and a Member-Supervisory Board at Guangdong Yuanning Pharmaceutical Co. Ltd.
Ms. Hong obtained an undergraduate degree from Guangdong Pharmaceutical University in 1993.
Aktive Positionen von Li Ping Hong
| Unternehmen | Position | Beginn |
|---|---|---|
| HONZ PHARMACEUTICAL CO., LTD. | Director/Board Member | 20.12.2007 |
| Hainan Honz Pharmaceutical Sales Co. Ltd. | Director/Board Member | - |
| Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd. | Director/Board Member | - |
Guangdong Yuanning Pharmaceutical Co. Ltd.
 Guangdong Yuanning Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Honz Pharmaceutical Co., Ltd., Guangdong Yuanning Pharmaceutical Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. Guangdong Yuanning Pharmaceutical Co. was acquired by Honz Pharmaceutical Co., Ltd. from Guangdong Yingkang Pharmaceutical Co. Ltd. on August 18, 2014 for $6.25 million. | Director/Board Member | - |
Guangdong Kangzhi Hospital Management Co., Ltd.
 Guangdong Kangzhi Hospital Management Co., Ltd. Packaged SoftwareTechnology Services Part of Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/, Guangdong Kangzhi Hospital Management Co., Ltd. develops computer software. The private company is based in Guangzhou, China. The Chinese company was founded in 2018. Li Ping Hong has been the CEO of the company since 2018. Guangdong Kangzhi Hospital Management Co. was acquired by Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/ from Tianjin Binhai Yuanxian Management Consulting Center LP on July 13, 2022 for $74.69 million. | Chief Executive Officer | 20.06.2018 |
Ausbildung von Li Ping Hong
| Guangdong Pharmaceutical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HONZ PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Beijing Shunxin Xiangyun Pharmaceutical Co. Ltd. | |
| Hainan Honz Pharmaceutical Sales Co. Ltd. | |
Guangdong Yuanning Pharmaceutical Co. Ltd.
Guangdong Yuanning Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Honz Pharmaceutical Co., Ltd., Guangdong Yuanning Pharmaceutical Co. Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. Guangdong Yuanning Pharmaceutical Co. was acquired by Honz Pharmaceutical Co., Ltd. from Guangdong Yingkang Pharmaceutical Co. Ltd. on August 18, 2014 for $6.25 million. | Health Technology |
Guangdong Kangzhi Hospital Management Co., Ltd.
Guangdong Kangzhi Hospital Management Co., Ltd. Packaged SoftwareTechnology Services Part of Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/, Guangdong Kangzhi Hospital Management Co., Ltd. develops computer software. The private company is based in Guangzhou, China. The Chinese company was founded in 2018. Li Ping Hong has been the CEO of the company since 2018. Guangdong Kangzhi Hospital Management Co. was acquired by Guangdong Kangzhi Hospital Management Co. Ltd. /Private Group/ from Tianjin Binhai Yuanxian Management Consulting Center LP on July 13, 2022 for $74.69 million. | Technology Services |
